# Lunsumio Velo

NDC: 50242-201
Generic name: Mosunetuzumab
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20251219

FDA application: BLA761263

## Active ingredients

- MOSUNETUZUMAB: 45 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a2b6dc2-48bd-4da7-a611-bc6bae2893c8